[Drostanolone propionate (masteril) in disseminated breast cancer in women. Immediate results].
Marinov
L
L
Tsekova
V
V
Koĭnov
K
K
Velikova
M
M
Micheva
D
D
D002293:Adenocarcinoma, Scirrhous / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000732:Androstanols / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D012074:Remission Induction
D000732:Androstanols; D000970:Antineoplastic Agents; C007561:dromostanolone propionate
Drostanolon-propionat (masteril) pri diseminiraniia rak na mlechna ta zhleza u zhenata. Neposredstveni rezultati.